MARKET

BMRN

BMRN

Biomarin Pharmaceutical Inc
NASDAQ
68.52
+4.71
+7.38%
Opening 14:26 08/10 EDT
OPEN
63.82
PREV CLOSE
63.81
HIGH
69.27
LOW
63.37
VOLUME
2.55M
TURNOVER
--
52 WEEK HIGH
69.27
52 WEEK LOW
49.26
MARKET CAP
13.26B
P/E (TTM)
184.74
1D
5D
1M
3M
1Y
5Y
1D
BioMarin (BMRN) Is Up 6.3% After Raising 2026 Revenue Guidance And Highlighting Voxzogo Momentum
Simply Wall St · 1d ago
BioMarin (BMRN) Stock Gains On Higher Outlook Despite Profit Drop
Simply Wall St · 2d ago
BioMarin Pharmaceutical Price Target Raised to $124.00/Share From $119.00 by Morgan Stanley
Dow Jones · 2d ago
BioMarin Pharmaceutical Is Maintained at Overweight by Morgan Stanley
Dow Jones · 2d ago
Morgan Stanley Maintains Overweight on BioMarin Pharmaceutical, Raises Price Target to $124
Benzinga · 2d ago
BioMarin price target raised to $86 from $80 at BofA
TipRanks · 3d ago
BioMarin Pharmaceutical Is Maintained at Outperform by Oppenheimer
Dow Jones · 3d ago
BioMarin Pharmaceutical Price Target Raised to $97.00/Share From $95.00 by Oppenheimer
Dow Jones · 3d ago
More
About BMRN
BioMarin Pharmaceutical Inc. is a global biotechnology company engaged in the development of genetic discovery into medicines that make an impact on the life of each patient. The Company has a portfolio of commercial therapies and a clinical and preclinical pipeline. Its commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno-associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Its Galafold (migalastat) is the first oral treatment for Fabry disease, and Pombiliti (cipaglucosidase alfa-atga) + Opfolda (miglustat), is a two-component therapy for Pompe disease.

Webull offers Biomarin Pharmaceutical Inc stock information, including NASDAQ: BMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMRN stock methods without spending real money on the virtual paper trading platform.